|
|
||||||||
Ann Thorac Surg 1995;59:1487-1490
© 1995 The Society of Thoracic Surgeons
Division of Cardiothoracic Surgery, University of California at San Diego Medical Center, San Diego, California
Accepted for publication February 16, 1995.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Primary tumors of the pulmonary arteries are rare. The clinical presentation closely resembles several more common conditions, so they seldom are diagnosed preoperatively. The etiology of these tumors remains obscure. Newer diagnostic techniques have helped in establishing earlier identification. The histopathologic characteristics are variable and precise identification is often difficult. Treatment is primarily surgical with the role of adjuvant therapy as yet not clearly defined. The prognosis remains poor.
Our institution has been engaged in a program for surgical correction of chronic pulmonary thromboembolic disease since 1970, and recently has reported the experience and results with 150 pulmonary thromboendarterectomy operations [1]. Patients are referred from all areas for evaluation of their progressive pulmonary dysfunction associated with pulmonary hypertension. In this pursuit we have encountered 6 cases of primary sarcoma of the pulmonary artery within the last 6 years. We present these cases, as well as their diagnosis and management, and review the literature.
| Material and Methods |
|---|
|
|
|---|
|
| Results |
|---|
|
|
|---|
|
| Comments |
|---|
|
|
|---|
The first case of pulmonary artery sarcoma was reported by Mandelstamm in 1923, and since then, there have been few reports in the literature [35], with the total number of cases reported only approaching 100. Although rare, the true incidence is unknown and probably understated. In our experience of pulmonary hypertension due to thromboembolic disease, patients generally do not present until well over half the pulmonary vasculature has been occluded, and even in the late stages of the disease the diagnosis is often missed. It is therefore likely that there are patients in whom pulmonary hypertension due to tumor is undiagnosed. Our interest in the surgical treatment of chronic thromboembolic disease has led to our encountering 6 of these patients in a 6-year period.
The clinical picture in our patients varied from mild dyspnea on exertion to respiratory distress and florid right heart failure. The usual history of patients with pulmonary artery tumors is one of progressive dyspnea, often with associated cough and chest pain. There may be coexisting signs of increasing right ventricular dysfunction. The presence of flow bruits over the pulmonary arteries is also suggestive. This clinical history is strikingly similar to that of patients with chronic thromboembolic disease. Although there was no strong history of previous deep venous thrombosis or pulmonary embolism in 4 of our 6 patients, only 50% of our pulmonary thromboendarterectomy patients here have no prior history of thromboembolism or deep venous thrombosis [1].
Once the diagnosis is entertained, an extensive work-up may be required. The evaluation of our patients included chest radiologic examination, ventilation-perfusion scintiscan, echocardiogram, right heart catheterization, bilateral pulmonary angiography, and often pulmonary angioscopy. Chest radiologic examination is usually nonspecific. However, hilar pulmonary artery dilatation, increased heart size, and a changed pulmonary vascular pattern, as well as secondary lesions, may arouse suspicion of a pulmonary artery tumor. Atypical patterns for pulmonary embolism seen on ventilation-perfusion scans, as well as pedunculated or lobulated lesions with ``to and fro'' motion, or smooth tapering and distal pruning of pulmonary vessels seen on pulmonary angiography is also characteristic. Echocardiography, computed tomography, and magnetic resonance imaging scanning can allow for direct imaging of the tumor. Computed tomographic scanning cannot differentiate between thrombus and tumor; however, it can visualize secondary lesions. Gadolinium-diethylene triamene pentaacetic acidenhanced magnetic resonance imaging may differentiate between vascularized tumor and intraluminal thrombus. Smith and colleagues [6] described magnetic and CT findings in pulmonary artery sarcoma, and they concluded that the tumor distribution of these lesions is highly distinctive and can be suggestive of the diagnosis. Preoperative histologic verification is generally not possible for vascular tumors; however, aspiration biopsy specimens may be obtained via pulmonary angioscopy, which allows direct visualization of the tumor.
The etiology of these tumors remains obscure. They have been related to the malignant degeneration of thrombus and the neoplastic transformation of primitive mesenchymal cells [79]. Grossly, these tumors are typically large and mucoid, and line or completely fill the pulmonary vessels but do not resemble thrombus (Fig 2
). Morphologic descriptions of tumor growth patterns include intimal, intraluminal, and adventitial. The World Health Organization has set criteria for histologic classification of vascular sarcomas based on stained sections [10]. Immunohistochemical studies using smooth muscle actin, desmin, and S100 protein can assist in identifying the tumors. Positive staining for factor VII-related antigen and QBend/CD34 can suggest primary endothelial origin. Finally, Burke and Virmani [11] recently presented a clinicopathologic study of sarcomas of the great vessels and reported a wide variety of histologic findings.
|
There were no cases of reperfusion edema after operation in this series. This is consistent with our experience in pulmonary thromboendarterectomy patients, in whom the incidence of clinically significant edema is now less than 10%.
The prognosis of these tumors depends largely on local recurrence. Length of survival of patients with primary pulmonary artery sarcomas is intermediate between that of patients with aortic and inferior vena caval sarcomas. Median length of survival without surgical resection is approximately 1.5 months, which is not affected by the addition of adjuvant therapy. Surgical resection has lengthened survival time to approximately 1 year. The addition of adjuvant radiotherapy and chemotherapy has extended this somewhat further. The survival times of our patients are consistent with these findings. The most beneficial protocols for this tumor, however, are yet to be described. Pulmonary metastases are present in up to 60% of patients, but extrathoracic disease is unusual. Thus, in the absence of distal disease, resection of pulmonary metastases after obtaining local control may provide a survival benefit. Distal microembolization is common; therefore, adjuvant chemotherapy, even in the absence of pulmonary nodules, would seem appropriate.
Our institution is involved actively in the evaluation and surgical therapy of patients with progressive pulmonary dysfunction related to chronic pulmonary thromboembolic disease, and we undoubtedly will continue to encounter primary pulmonary artery sarcomas in this endeavor. The extensive preoperative work-up currently used, perhaps with the addition of computed tomography and magnetic resonance imaging, should allow for earlier preoperative diagnosis. When clinicians encounter patients with advancing pulmonary failure who have an atypical history with findings suggestive of pulmonary artery occlusion, the diagnosis of pulmonary artery tumor must be considered. Emphasis should be placed on early identification of these lesions. As evidenced by our patients with an average duration of symptoms of 17 months, diagnosis is often delayed and the tumor is incurable. Total surgical resection with the addition of chemotherapy, radiotherapy, or both, or excision of all gross tumor in combination with adjuvant treatment should offer these patients significant palliation and an opportunity for increased length of survival.
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Fernandez-Golfin, P. Escribano, J. Cortina, R. Tello, F. Hernandez, F. Lopez-Rios, J. Delgado Jimenez, and C. Saenz de la Calzada Management of Primary Pulmonary Artery Sarcoma: Experience of a Single Center Angiology, October 1, 2008; 59(5): 636 - 639. [Abstract] [PDF] |
||||
![]() |
H. K. Kim, Y. S. Choi, K. Kim, Y. M. Shim, K. Sung, Y. T. Lee, P. W. Park, and J. Kim Surgical treatment for pulmonary artery sarcoma Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 712 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakahira, H. Ogino, H. Sasaki, and N. Katakami Long-term survival of a pulmonary artery sarcoma produced by aggressive surgical resection and adjuvant chemoradiotherapy Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 388 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Maruo, Y. Okita, K. Okada, T. Yamashita, S. Tobe, and N. Tanimura Surgical Experience for the Pulmonary Artery Sarcoma Ann. Thorac. Surg., December 1, 2006; 82(6): 2014 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Heid, S. Guth, E. Mayer, S. Herber, C. Duber, I. Tzanova, and C. Werner Extracorporeal Circulation and Cardiac Arrest in an Awake Patient: A Safe Approach for Single Lung Pulmonary Artery Stenting? Ann. Thorac. Surg., August 1, 2006; 82(2): 746 - 747. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Alsoufi, M. Slater, P. P Smith, T. Karamlou, A. Mansoor, and P. Ravichandran Pulmonary artery sarcoma mimicking massive pulmonary embolus: a case report. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): e71 - e73. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Shanmugam Primary cardiac sarcoma. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 925 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Thistlethwaite, M. Mo, M. M. Madani, R. Deutsch, D. Blanchard, D. P. Kapelanski, and S. W. Jamieson Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1203 - 1211. [Abstract] [Full Text] |
||||
![]() |
E. Mayer, J. Kriegsmann, A. Gaumann, H. U. Kauczor, M. Dahm, U. Hake, F. X. Schmid, and H. Oelert Surgical treatment of pulmonary artery sarcoma J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0077 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mandel and E. J. Mark Case 25-2000- A 69-Year-Old Woman with Pleuritic Pain and Pulmonary Arterial Obstruction N. Engl. J. Med., August 17, 2000; 343(7): 493 - 500. [Full Text] [PDF] |
||||
![]() |
P. Dumont, P. Diot, M. R. Aupart, and B. Toumieux Leiomyosarcoma of the pulmonary artery Ann. Thorac. Surg., December 1, 1998; 66(6): 2089 - 2091. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Babatasi, M. Massetti, F. Galateau, and A. Khayat Leiomyosarcoma of the pulmonary veins extending into the left atrium or left atrial leiomyosarcoma: Multimodality therapy J. Thorac. Cardiovasc. Surg., October 1, 1998; 116(4): 665 - 666. [Full Text] |
||||
![]() |
G. B. Luciani, A. Mazzucco, J. E. Dussek, and C. Akomea-Agyin Surgical Management of Primary Pulmonary Artery Sarcoma Ann. Thorac. Surg., February 1, 1997; 63(2): 601 - 602. [Full Text] |
||||
![]() |
A. Mazzucco, F. Santini, and S. W. Jamieson The surgical challenge of primary pulmonary artery sarcoma. Ann. Thorac. Surg., January 1, 1996; 61(1): 278 - 279. [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |